Compounded options are not FDA-approved finished drug products, and their availability in 2026 is actively subject to regulatory change
In our opinion, the lack of effectiveness could be due to the absence of the active ingredients approved by the FDA or EMA, or to non-compliant dosages, as reported in some cases documented by the Regulatory Authorities (Liguori et al., 2023)
Additionally, the formula includes hyaluronic acid and sodium ascorbate
PlexusDx Precision Peptide Genetic Test identifies key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313markers that directly influence appetite regulation and metabolism
It has been used extensively in animal studies, human cell models, and increasingly in off-label therapeutic settings, with minimal toxicity or organ stress reported
Your provider can adjust dosing or discuss alternative options based on your response